Cargando…

Immunomodulation as a Protective Strategy in Chronic Otitis Media

INTRODUCTION: Major features of the pathogenesis in otitis media, the most common disease in childhood, include hyperplasia of the middle ear mucosa and infiltration by leukocytes, both of which typically resolve upon bacterial clearance via apoptosis. Activation of innate immune receptors during th...

Descripción completa

Detalles Bibliográficos
Autores principales: Leichtle, Anke, Kurabi, Arwa, Leffers, David, Därr, Markus, Draf, Clara Sophia, Ryan, Allen Frederic, Bruchhage, Karl-Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005906/
https://www.ncbi.nlm.nih.gov/pubmed/35433505
http://dx.doi.org/10.3389/fcimb.2022.826192
_version_ 1784686558793695232
author Leichtle, Anke
Kurabi, Arwa
Leffers, David
Därr, Markus
Draf, Clara Sophia
Ryan, Allen Frederic
Bruchhage, Karl-Ludwig
author_facet Leichtle, Anke
Kurabi, Arwa
Leffers, David
Därr, Markus
Draf, Clara Sophia
Ryan, Allen Frederic
Bruchhage, Karl-Ludwig
author_sort Leichtle, Anke
collection PubMed
description INTRODUCTION: Major features of the pathogenesis in otitis media, the most common disease in childhood, include hyperplasia of the middle ear mucosa and infiltration by leukocytes, both of which typically resolve upon bacterial clearance via apoptosis. Activation of innate immune receptors during the inflammatory process leads to the activation of intracellular transcription factors (such as NF-κB, AP-1), which regulate both the inflammatory response and tissue growth. We investigated these leading signaling pathways in otitis media using mouse models, human samples, and human middle ear epithelial cell (HMEEC) lines for therapeutic immunomodulation. METHODS: A stable otitis media model in wild-type mice and immunodeficient KO-mice, as well as human tissue samples from chronic otitis media, skin from the external auditory canal and middle ear mucosa removed from patients undergoing ear surgery, were studied. Gene and protein expression of innate immune signaling molecules were evaluated using microarray, qPCR and IHC. In situ apoptosis detection determined the apoptotic rate. The influence of bacterial infection on immunomodulating molecules (TNFα, MDP, Tri-DAP, SB203580, Cycloheximide) in HMEEC was evaluated. HMEEC cells were examined after bacterial stimulation/inhibition for gene expression and cellular growth. RESULTS: Persistent mucosal hyperplasia of the middle ear mucosa in chronic otitis media resulted from gene and protein expression of inflammatory and apoptotic genes, including NODs, TNFα, Casp3 and cleaved Casp3. In clinical chronic middle ear samples, these molecules were modulated after a specific stimulation. They also induced a hyposensitive response after bacterial/NOD-/TLR-pathway double stimulation of HMEEC cells in vitro. Hence, they might be suitable targets for immunological therapeutic approaches. CONCLUSION: Uncontrolled middle ear mucosal hyperplasia is triggered by TLRs/NLRs immunoreceptor activation of downstream inflammatory and apoptotic molecules.
format Online
Article
Text
id pubmed-9005906
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90059062022-04-14 Immunomodulation as a Protective Strategy in Chronic Otitis Media Leichtle, Anke Kurabi, Arwa Leffers, David Därr, Markus Draf, Clara Sophia Ryan, Allen Frederic Bruchhage, Karl-Ludwig Front Cell Infect Microbiol Cellular and Infection Microbiology INTRODUCTION: Major features of the pathogenesis in otitis media, the most common disease in childhood, include hyperplasia of the middle ear mucosa and infiltration by leukocytes, both of which typically resolve upon bacterial clearance via apoptosis. Activation of innate immune receptors during the inflammatory process leads to the activation of intracellular transcription factors (such as NF-κB, AP-1), which regulate both the inflammatory response and tissue growth. We investigated these leading signaling pathways in otitis media using mouse models, human samples, and human middle ear epithelial cell (HMEEC) lines for therapeutic immunomodulation. METHODS: A stable otitis media model in wild-type mice and immunodeficient KO-mice, as well as human tissue samples from chronic otitis media, skin from the external auditory canal and middle ear mucosa removed from patients undergoing ear surgery, were studied. Gene and protein expression of innate immune signaling molecules were evaluated using microarray, qPCR and IHC. In situ apoptosis detection determined the apoptotic rate. The influence of bacterial infection on immunomodulating molecules (TNFα, MDP, Tri-DAP, SB203580, Cycloheximide) in HMEEC was evaluated. HMEEC cells were examined after bacterial stimulation/inhibition for gene expression and cellular growth. RESULTS: Persistent mucosal hyperplasia of the middle ear mucosa in chronic otitis media resulted from gene and protein expression of inflammatory and apoptotic genes, including NODs, TNFα, Casp3 and cleaved Casp3. In clinical chronic middle ear samples, these molecules were modulated after a specific stimulation. They also induced a hyposensitive response after bacterial/NOD-/TLR-pathway double stimulation of HMEEC cells in vitro. Hence, they might be suitable targets for immunological therapeutic approaches. CONCLUSION: Uncontrolled middle ear mucosal hyperplasia is triggered by TLRs/NLRs immunoreceptor activation of downstream inflammatory and apoptotic molecules. Frontiers Media S.A. 2022-03-30 /pmc/articles/PMC9005906/ /pubmed/35433505 http://dx.doi.org/10.3389/fcimb.2022.826192 Text en Copyright © 2022 Leichtle, Kurabi, Leffers, Därr, Draf, Ryan and Bruchhage https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Leichtle, Anke
Kurabi, Arwa
Leffers, David
Därr, Markus
Draf, Clara Sophia
Ryan, Allen Frederic
Bruchhage, Karl-Ludwig
Immunomodulation as a Protective Strategy in Chronic Otitis Media
title Immunomodulation as a Protective Strategy in Chronic Otitis Media
title_full Immunomodulation as a Protective Strategy in Chronic Otitis Media
title_fullStr Immunomodulation as a Protective Strategy in Chronic Otitis Media
title_full_unstemmed Immunomodulation as a Protective Strategy in Chronic Otitis Media
title_short Immunomodulation as a Protective Strategy in Chronic Otitis Media
title_sort immunomodulation as a protective strategy in chronic otitis media
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005906/
https://www.ncbi.nlm.nih.gov/pubmed/35433505
http://dx.doi.org/10.3389/fcimb.2022.826192
work_keys_str_mv AT leichtleanke immunomodulationasaprotectivestrategyinchronicotitismedia
AT kurabiarwa immunomodulationasaprotectivestrategyinchronicotitismedia
AT leffersdavid immunomodulationasaprotectivestrategyinchronicotitismedia
AT darrmarkus immunomodulationasaprotectivestrategyinchronicotitismedia
AT drafclarasophia immunomodulationasaprotectivestrategyinchronicotitismedia
AT ryanallenfrederic immunomodulationasaprotectivestrategyinchronicotitismedia
AT bruchhagekarlludwig immunomodulationasaprotectivestrategyinchronicotitismedia